Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]†: Profile Report

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.14, Iss.1, 2012-02, pp. : 67-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

By Duggan Sean T.

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1973-1986

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults

By Sanford Mark

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Immunogenicity of pneumococcal 13-valent conjugate vaccine

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

South Africa plans to phase in routine vaccination with pneumococcal 7-valent CRM197 vaccine conjugate [Prevenar]

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pneumococcal 7-valent CRM197 vaccine conjugate: Lack of efficacy in pneumococcal meningitis in a child: case report

Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite